NAUTNautilus Biotechnology, Inc.

0.9545USD+5.79%Mkt Cap: 121.30M $P/E:

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops N…

Key Statistics

Company
Market Cap121.30M $
Enterprise Value58.61M $
Revenue (TTM)190.00K $
Gross Profit175.00K $
Net Income (TTM)-59.00M $
Revenue/Share0.0020 USD
Last Price0.9545 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees127
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.22
PEG
EV/EBITDA-0.95
EV/Revenue308.46
P/S604.33
P/B0.88
EPS (TTM)-0.45
EPS (Forward)-0.74
52W Range
0.62009% of range4.310
52W High4.310 USD
52W Low0.6200 USD
Profitability
Gross Margin92.11%
Oper. Margin-8296.32%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-37.59%
ROA-30.87%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-50.70M $
CapEx (TTM)1.28M $
FCF Margin-15483.36%
FCF Yield-24.25%
Net Debt-56.22M $
Net Debt/EBITDA0.92
Balance Sheet
Debt/Equity0.19
Current Ratio10.14
Quick Ratio9.73
Book Value/Sh1.031 USD
Cash/Share0.6600 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)4.000 USD
Upside (mean)+319.1%
Target Range4.000 USD4.000 USD
# Analysts1
Ownership
Shares Out.127.08M
Float58.40M
Insiders32.02%
Institutions45.23%
Short Interest
Short Ratio2.3d
Short % Float3.63%
Short % Out.1.79%
Shares Short2.27M
Short (prev mo.)829.52K
Technical
SMA 501.579 (-39.5%)
SMA 2002.208 (-56.8%)
Beta0.87
S&P 52W Chg18.16%
Avg Vol (30d)819.66K
Avg Vol (10d)579.14K
Technical Indicators
RSI (14)31.1
MACD-0.2107
MACD Signal-0.2466
MACD Hist.+0.0359
BB Upper1.495 USD
BB Middle1.019 USD
BB Lower0.5435 USD
BB Width93.35%
ATR (14)0.0972 USD
Vol Ratio (20d)0.96x